New report projects healthcare AI market growth from $28 billion in 2026 to $188 billion by 2030, driven by AI diagnostics, drug discovery, and personalized medicine.
A new industry report projects the global healthcare AI market will grow from $28 billion in 2026 to $188 billion by 2030, representing a compound annual growth rate of 31%. The growth is driven by expanding applications in diagnostics, drug discovery, and personalized medicine.
AI-powered diagnostic tools are seeing the fastest adoption, with AI systems now outperforming human radiologists in detecting certain cancers. Drug discovery AI has accelerated the identification of promising drug candidates, reducing development timelines by years in some cases.
"Healthcare is undergoing its most significant transformation in a century," said the report's author. "AI isn't just improving efficiency—it's enabling entirely new approaches to treating disease."
Key growth areas include AI-powered medical imaging (projected $45 billion by 2030), clinical decision support ($38 billion), drug discovery ($32 billion), and personalized medicine ($28 billion).
The report notes regulatory approval remains a bottleneck, with FDA and EMA approvals for AI medical devices increasing 40% year-over-year but still representing a fraction of development-stage products.
